Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan

Author:

Chien Rong-Nan12ORCID,Lu Sheng-Nan13,Hui-Min Wu Grace14,Yang Wen-Wen1,Pwu Raoh-Fang15,Liu Chia-Ling1,Cheng Kuo-Pen1,Chen Shih-Chung1,Chen Chien-Jen16

Affiliation:

1. Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare , Taipei , Taiwan

2. Liver Research Unit, Linkou Chang Gung Memorial Hospital and University , Taoyuan , Taiwan

3. Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital , Kaohsiung , Taiwan

4. Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University , Taipei , Taiwan

5. School of Health Care Administration, Taipei Medical University , Taipei , Taiwan

6. Genomics Research Center, Academia Sinica , Taipei , Taiwan

Abstract

Abstract The estimated prevalence of anti-HCV was 3.1% in Taiwan. Studies have shown iatrogenic behavior was the major transmission route. It is highest in specific populations including patients with end stage renal disease (ESRD), human immunodeficiency virus infection, who inject drug (PWID), and under opioid substitution treatment. Approximately 405,160 patients were seropositive for HCV RNA and in need of treatment. Taiwan government claims to reach WHO’s 2030 goal of HCV elimination by 2025 and works hard to resolve several barriers of HCV elimination including political commitment, sustainable financing, minimize reimbursement restrictions, instituted monitoring, and perform micro-elimination of specific populations. The last stage of HCV elimination is to accelerate the universal HCV screening program of populations aged 45-79 years and resolve the unawareness issue of HCV infection. Hopefully, we can achieve the targets of HCV elimination set by WHO and reach the goal earlier in 2025.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3